Columbia Tech Ventures
Columbia Tech Ventures
Columbia Technology Ventures
Columbia Technology Ventures is the tech transfer office of Columbia University. Our core objective is to facilitate the transfer of inventions from academic research to outside organizations for the benefit of society on a local, national and global basis. Each year, CTV manages more than 330 invention disclosures from faculty, 70 license deals and 15 new start-ups, involving approximately 45 multi-disciplinary, full-time staff across Columbia's two campuses. CTV currently has over 1200 patent assets available for licensing, across research fields such as bio, IT, cleantech, devices, nanotechnology, and material science.
AUTM 'VCs Talk Back' Part 2 - Deb Palistrant and Josh Resnick with Orin Herskowitz
AUTM 'VCs Talk Back' Part 2 - Deb Palistrant and Josh Resnick with Orin Herskowitz by Columbia Technology Ventures
Apr 3, 2020
45 min
AUTM 'VCs Talk Back' Part 1
AUTM 'VCs Talk Back' Part 1 by Columbia Technology Ventures
Mar 23, 2020
44 min
Patent Monetization & Enforcement Tales From The Trenches
Panel discussion with Garrard Beeney (Partner and Co-Head of the Intellectual Property and Technology Group at Sullivan & Cromwell), Ian McClure (Director at the Office of Technology Commercialization at the University of Kentucky, and former IPXI), Phil Hartstein (President and CEO of Finjan), John Veschi (CEO of Marquis Technologies and Former CEO of Rockstar), and Jeff Sears (Associate General Counsel and Chief Patent Counsel at Columbia University) covering such questions as “What is ‘efficient infringement’ and how have the new patent laws changed the licensing landscape?” (minute 1), “Advice for startups who believe their IP is being infringed by large companies?” (minute 14), “Advice on patent strategies for tech startups, vs. biopharma startups?” (minute 19); “What advice would you give the new Presidential, Secretary of Commerce, and the Director of the USPTO about intellectual property policy over the next 4 years?” (minute 28).
Mar 13, 2017
35 min
VC And Entrepreneur Perspectives On IP
Panel discussion between Sean Dalton (Partner at Highland Capital Partners), Joe Ellis (CEO and Co-Founder of vidRovr), Hemai Parthasarathy (Scientific Director of Breakout Labs, Thiel Foundation), Nina Tandon (CEO and Co-Founder of EpiBone), and Misti Ushio (CEO of TARA Biosystems). The first 35 minutes are largely introductions to each of the panelists, explaining their career paths that lead them to becoming entrepreneurs or investors. The next 45 minutes are a lively panel discussion answering questions such as “What role does IP play in starting a company” (minute 35), “how do license deals get negotiated and what are common terms, especially with university startups” (minute 50), “best practices for startups on how to build a cost-effective IP filing strategy” (minute 62); “why does IP have particularly important value at the beginning and end of a startup’s lifecycle?” (minute 65), “advice for students who want to be entrepreneurs and investors?” (minute 67).
Feb 27, 2017
1 hr 12 min
Patents 101 with Jeff Sears, Columbia's Chief Patent Counsel 2016
Hear Jeffrey M. Sears, PhD, Chief Patent Counsel for Columbia University, present a patent law primer focusing on what you need to know to preserve patent protection for your inventions.
Jan 27, 2017
1 hr 6 min
SBIRs & STTRs: The Inside Story
On March 4 2016, former U.S. Small Business Administration’s Associate Administrator Javier Saade held an informational session on federal Small Business Innovation Research / Small Business Technology Transfer (SBIR/STTR) grants. This session offers insight into the requirements of these highly competitive programs and ways to get an edge when applying for these research grants.
Jul 20, 2016
1 hr
Is This An Invention? Now What?
Listen to a panel discussion with Jeff Sears (Columbia's Chief Patent Counsel), Ofra Weinberger (Director of Licensing, CTV) and Ron Katz, (Senior Technology Licensing Officer, CTV) to explore invention disclosure, patenting, and the technology commercialization process. moderated by Columbia WIN member Dr. Anjali Saqi, professor of Pathology and Cell Biology at Columbia University Medical Center.
Jul 11, 2016
59 min
Patenting & Licensing Of Early-Stage University Technology
Columbia Technology Ventures’ Executive Director Orin Herskowitz discusses the fast-changing and ever-growing world of patenting and licensing early-stage university technologies, including examples of scientific inventions, how patent decisions get made, and how license agreements are negotiated, both within Columbia and across the industry.
Apr 4, 2016
1 hr 8 min
Venture Capital Perspective with Carlo Rizzuto, Versant Ventures
Featuring a discussion and Q&A with Carlo Rizzuto, operating principal of Versant Ventures, a leading healthcare investment firm investing across the sector at all stages, with an emphasis on early-stage investment in therapeutics. In this video Carlo discusses Versant Ventures’ new $300 million fund for investing in bioscience, as well as other recent exciting developments and trends in venture capital and healthcare investing.
Apr 4, 2016
1 hr 6 min
Venture Capital 101 with Osage University Partners
While venture capital investment is on the rise, the number of start-ups has also exploded, and competition for VC dollars is fierce. In this podcast, John Lee, Matthew Cohen, Louis P. Berneman of Osage University Partners offer insight into the decision-making process for VC firms and shed light on what VC funding can do for your start-up.
Apr 4, 2016
1 hr 30 min
Load more